Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Loading metrics

Open Access

Correction

Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib

The PLOS ONE Staff

Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib

The PLOS ONE Staff

x

Published: June 25, 2020
https://doi.org/10.1371/journal.pone.0235580

Reader Comments (0)

Post a new comment on this article